Structure-Activity Relationship Studies of Antimalarial


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
26 01 2023
Historique:
pmc-release: 26 01 2024
pubmed: 12 1 2023
medline: 28 1 2023
entrez: 11 1 2023
Statut: ppublish

Résumé

With increasing reports of resistance to artemisinins and artemisinin-combination therapies, targeting the

Identifiants

pubmed: 36630286
doi: 10.1021/acs.jmedchem.2c01651
pmc: PMC10157299
mid: NIHMS1891577
doi:

Substances chimiques

Antimalarials 0
Proteasome Endopeptidase Complex EC 3.4.25.1
Proteasome Inhibitors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1484-1508

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI139179
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143714
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI123794
Pays : United States
Organisme : NIH HHS
ID : S10 OD028556
Pays : United States

Références

Nat Rev Dis Primers. 2017 Aug 03;3:17050
pubmed: 28770814
J Med Chem. 2022 Jul 14;65(13):9350-9375
pubmed: 35727231
Int J Parasitol Drugs Drug Resist. 2012 Jan 09;2:1-10
pubmed: 24533266
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39):
pubmed: 34548400
PLoS Biol. 2015 Apr 22;13(4):e1002132
pubmed: 25901609
Angew Chem Int Ed Engl. 2021 Apr 19;60(17):9279-9283
pubmed: 33433953
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3181-6
pubmed: 17383878
Anal Chim Acta. 2006 Feb 10;559(1):37-44
pubmed: 16636700
Nature. 2009 Oct 1;461(7264):621-6
pubmed: 19759536
J Am Chem Soc. 2014 Oct 1;136(39):13562-5
pubmed: 25226494
J Med Chem. 2012 Jun 14;55(11):4877-95
pubmed: 22506484
N Engl J Med. 2021 Sep 23;385(13):1163-1171
pubmed: 34551228
Chem Biol. 2012 Dec 21;19(12):1535-45
pubmed: 23142757
PLoS Pathog. 2021 Dec 9;17(12):e1010058
pubmed: 34882737
ACS Chem Biol. 2014 Aug 15;9(8):1869-76
pubmed: 24918547
Lancet. 2009 Oct 24;374(9699):1418-9
pubmed: 19854365
ACS Infect Dis. 2021 Jul 9;7(7):1923-1931
pubmed: 33971094
J Am Chem Soc. 2018 Sep 12;140(36):11424-11437
pubmed: 30107725
Nature. 2016 Feb 11;530(7589):233-6
pubmed: 26863983
Lancet Microbe. 2021 Sep;2(9):e441-e449
pubmed: 34553183
ACS Infect Dis. 2021 Feb 12;7(2):333-346
pubmed: 33400499
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6863-E6870
pubmed: 29967165
Nature. 2016 Sep 8;537(7619):229-233
pubmed: 27501246
Science. 2018 May 4;360(6388):
pubmed: 29724925

Auteurs

Hao Zhang (H)

Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

John Ginn (J)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Wenhu Zhan (W)

Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

Annie Leung (A)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

Yi J Liu (YJ)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

Akinori Toita (A)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Rei Okamoto (R)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Tzu-Tshin Wong (TT)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Toshihiro Imaeda (T)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Ryoma Hara (R)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Mayako Michino (M)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Takafumi Yukawa (T)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Sevil Chelebieva (S)

Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States.

Patrick K Tumwebaze (PK)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Jeremie Vendome (J)

Schrödinger, Inc., New York, New York 10036, United States.

Thijs Beuming (T)

Schrödinger, Inc., New York, New York 10036, United States.

Kenjiro Sato (K)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Kazuyoshi Aso (K)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Philip J Rosenthal (PJ)

Department of Medicine, University of California, San Francisco, California 94143, United States.

Roland A Cooper (RA)

Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States.

Nigel Liverton (N)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Michael Foley (M)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Peter T Meinke (PT)

Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.

Carl F Nathan (CF)

Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

Laura A Kirkman (LA)

Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

Gang Lin (G)

Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH